<DOC>
	<DOCNO>NCT00119717</DOCNO>
	<brief_summary>The purpose study assess safety efficacy NeuroFlo™ catheter use patient ischemic stroke . The NeuroFlo device intend increase blood flow brain potentially reduce damage cause stroke .</brief_summary>
	<brief_title>Safety Efficacy NeuroFlo Technology Ischemic Stroke ( SENTIS )</brief_title>
	<detailed_description>The study prospective , control , randomize , single-blind , multi-center study NeuroFlo treatment plus standard medical management versus standard medical management alone . Randomization 1:1 stratify ensure equivalent patient distribution treatment control follow key parameter : 1 . National Institute Health Stroke Scale ( NIHSS ) baseline ( stratify &lt; 10 , 11-18 ) 2 . Time symptom onset ( TFSO ) time baseline NIHSS evaluation ( stratify &lt; 5 hr , ≥5 hr ) .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Ischemic stroke NIHSS 518 Time symptom onset less 14 hour Hemorrhagic stroke Certain type heart disease Kidney disease Other condition doctor ass</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>acute</keyword>
	<keyword>ischemic</keyword>
	<keyword>stroke</keyword>
	<keyword>randomize</keyword>
	<keyword>device</keyword>
	<keyword>treatment</keyword>
</DOC>